COVID-19 Recovery: Building future pandemic preparedness and understanding citizen engagement in the G7
- Open for applications
- Early-career, Established researcher, Mid-career, Postdoctoral or equivalent research, Senior researcher
Funded by the UK’s Department for Business, Energy and Industrial Strategy.
This programme provides UK and G7-based researchers at any career stage, and active in any discipline within the humanities and social sciences, to submit proposals focused on vaccine engagement, including examples of community confidence and hesitancy in Japan, Canada, Italy, Germany and France.
COVID-19 is the most challenging health crisis we have faced for decades. Its impacts are changing lives, communities and economies, but these challenges are not new. There are lessons we can learn from history and recent experience, such as the response to Ebola in recent years and research on other global vaccine campaigns such as polio. Evidence from the social sciences and humanities is critical to our recovery and how we can shape a positive future.
Moreover, COVID-19 is not impacting individuals, communities, families, countries and other groupings in isolation. The experience of COVID-19 is taking place in differing and dynamic contexts; individuals and communities are living through their own social, moral and material situations. For example, pre-existing and long-standing structural inequalities and historical injustices seem to be playing an especially important role in the impacts of COVID-19, the dialogues around vaccination and the trustworthiness of those communicating in the current environment of uncertainty. There is good reason to believe that vaccine engagement is weaker amongst disadvantaged groups, and, crucially, that this is a logical consequence of structural disadvantage and discrimination.
The aim of this call is to facilitate global and interconnected learning about the contexts, causes and factors leading to vaccine engagement by supporting research within each country of the G7. Applications on these issues must demonstrate a dedicated focus on place and context at local and community levels, as well as an ability to connect learning to national and international dynamics.
Projects can and should build on existing or ongoing research, but should ultimately allow us to establish an evidence base that can be used to answer the questions:
- How does context-specific to place, culture, social, political and economic factors shape people’s responses to vaccines?
- How can we harness existing knowledge to develop, disseminate and employ community-engaged research which works for and with national and regional public health authorities and community actors and researchers before, during and after vaccine deployment programs?
The lead applicant must be a researcher from the humanities or social sciences and be based at an eligible UK university or research institute. The lead applicant must be of postdoctoral status or above (or have equivalent research experience) and the PI’s position must last at least the duration of the grant funded by the Academy.
Projects can involve up to three Co-Applicants and must include at least one named Co-Applicant who will be actively assisting in the direction and management of at least parts of the project. Collaboration between researchers in different institutions is encouraged where appropriate and we expect to see PIs and Co-Applicants based in both the UK and elsewhere in the G7.
For more details about the programme and the eligibility requirements, please see the scheme notes.
Value and duration
Awards of five months in duration and up to £100,000 are available.
Funding can be used to support the time of the Principal Investigator and Co-Applicants; research assistance; travel, fieldwork and related expenses; and networking costs. Awards are offered on an 80 per cent full economic costing basis.
Projects must begin on 27 October 2021.
Applications must be submitted online using the British Academy's Grant Management System (GMS), Flexi-Grant®.
The deadline for submissions and UK institutional approval is on 6 October 2021, 17:00, UK time.